Rivastigmine Tartrate is the tartrate salt form of rivastigmine, a phenylcarbamate derivative exhibiting cognitive stimulating property. Although the mechanism of action has not been fully elucidated, rivastigmine tartrate may bind reversibly to cholinesterase, thereby decreasing the breakdown of acetylcholine and enhancing cholinergic function. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rivastigmine Hydrogen Tartrate, ENA 713, Rivastigmine bitartrate, Rivastach, Exelon TDS and Nimvastid (TN). Its PubChem CID is 6918078.
Rivastigmine tartrate
| CAS No | 129101-54-8 |
|---|---|
| Molecular Formula | C18H28N2O8 |
| Molecular Weight | 400.4 g/mol |
| Synonyms | (2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rivastigmine Tartrate is the tartrate salt form of rivastigmine, a phenylcarbamate derivative exhibiting cognitive stimulating property.
The listed CAS number is 129101-54-8.
The listed molecular formula is C18H28N2O8.
The listed molecular weight is 400.4 g/mol.
(2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate.
The source lists Rivastigmine Hydrogen Tartrate, ENA 713, Rivastigmine bitartrate, Rivastach, Exelon TDS and Nimvastid (TN).